The purpose of this study was to see how chrysin and/or bone marrow-derived
mesenchymal stem cells (BM-MSCs) affected streptozotocin (STZ)/nicotinamide (NA) …

Type 1 diabetes mellitus (T1DM) was established to be ameliorated by islet transplantation,
but the shortage of the transplanted human islet tissue and the use of immunosuppressive …

Objectives To compare the therapeutic potential of rat bone marrow-derived mesenchymal
stem cells (BM-MSCs) preconditioned ex-vivo with resveratrol (MCR) and BM-MSCs isolated …

One of the most promising treatments for diabetes mellitus (DM) is stem cell therapy. This
study is aimed at elucidating the antidiabetic effect of mesenchymal stem cells (MSCs) on …

Background Nowadays, diabetes mellitus is known as a silent killer because individual is
not aware that he has the disease till the development of its complications. Many …

Purpose High glucose environment in diabetes mellitus induces the dysfunction of bone
marrow-derived mesenchymal stromal cells (BMSCs) and impairs bone regeneration …

Type 2 diabetes mellitus is the most common endocrine disease all over the world, while
existing therapies can only ameliorate hyperglycemia or temporarily improve the response …

Chrysin (CH) is a natural flavonoid with pharmacological influences. The purpose of the
current study was the assessment of possible protective effects of CH against oxidative …

Extensive knowledge of diabetes and its complications is helpful to find new drugs for proper
treatment to stop degenerative changes derived from this disease. In this context, chrysin (5 …

Aim of the work The present study was carried out to investigate the therapeutic effect of
mesenchymal stem cells (MSCs) in the recovery of streptozotocin (STZ)-induced diabetes …